As of 2024-10-07, the Relative Valuation of Emergent BioSolutions Inc (EBS) is (208.91) USD. This relative valuation is based on P/E multiples. With the latest stock price at 9.35 USD, the upside of Emergent BioSolutions Inc based on Relative Valuation is -2334.3%.
The range of the Relative Valuation is (179.29) - (241.23) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 16.5x - 22.2x | 19.4x |
| Forward P/E multiples | 15.2x - 23.0x | 19.1x |
| Fair Price | (179.29) - (241.23) | (208.91) |
| Upside | -2017.6% - -2680.0% | -2334.3% |
| Date | P/E |
| 2024-10-04 | -0.86 |
| 2024-10-03 | -0.82 |
| 2024-10-02 | -0.85 |
| 2024-10-01 | -0.78 |
| 2024-09-30 | -0.77 |
| 2024-09-27 | -0.69 |
| 2024-09-26 | -0.67 |
| 2024-09-25 | -0.55 |
| 2024-09-24 | -0.56 |
| 2024-09-23 | -0.56 |
| 2024-09-20 | -0.60 |
| 2024-09-19 | -0.64 |
| 2024-09-18 | -0.63 |
| 2024-09-17 | -0.63 |
| 2024-09-16 | -0.67 |
| 2024-09-13 | -0.72 |
| 2024-09-12 | -0.70 |
| 2024-09-11 | -0.70 |
| 2024-09-10 | -0.72 |
| 2024-09-09 | -0.71 |
| 2024-09-06 | -0.69 |
| 2024-09-05 | -0.70 |
| 2024-09-04 | -0.68 |
| 2024-09-03 | -0.68 |
| 2024-08-30 | -0.76 |
| 2024-08-29 | -0.82 |
| 2024-08-28 | -0.82 |
| 2024-08-27 | -0.85 |
| 2024-08-26 | -0.86 |
| 2024-08-23 | -0.88 |
| 2024-08-22 | -0.87 |
| 2024-08-21 | -0.97 |
| 2024-08-20 | -0.89 |
| 2024-08-19 | -1.11 |
| 2024-08-16 | -0.99 |
| 2024-08-15 | -0.80 |
| 2024-08-14 | -0.70 |
| 2024-08-13 | -0.62 |
| 2024-08-12 | -0.61 |
| 2024-08-09 | -0.65 |
| 2024-08-08 | -0.77 |
| 2024-08-07 | -0.53 |
| 2024-08-06 | -0.91 |
| 2024-08-05 | -0.89 |
| 2024-08-02 | -0.93 |
| 2024-08-01 | -0.97 |
| 2024-07-31 | -1.17 |
| 2024-07-30 | -1.09 |
| 2024-07-29 | -1.36 |
| 2024-07-26 | -1.29 |